Updated findings from a nirmatrelvir/ritonavir (Paxlovid) trial in standard-risk COVID-19 suggest the antiviral's benefits are less clear for those not at high risk of severe outcomes.
Although Hispanics hold “largely trusting” views about scientists, about 6 in 10 feel Latino scientists aren’t visible enough in successful STEM jobs, according to survey results released Tuesday by the Pew Research Center...
Recent Comments